Stryker (SYK) Cash & Current Investments (2009 - 2026)
Stryker's (SYK) quarterly Cash & Current Investments came in at $2.9 billion in Q1 2026, up 24.05% year-on-year from $2.3 billion in Q1 2025, and down 29.8% on a QoQ basis from $4.1 billion in Q4 2025.
Stryker (SYK) Cash & Current Investments (2009 - 2026) Analysis & Trends
Stryker (SYK) has 18 years of Cash & Current Investments data on file, last reported at $2.9 billion in Q1 2026.
- On a quarterly basis, Cash & Current Investments rose 24.05% year-over-year to $2.9 billion in Q1 2026; TTM through Mar 2026 was $2.9 billion, a 24.05% increase from a year earlier, with the FY2025 full-year figure at $4.1 billion, up 9.54% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $2.9 billion, down from $4.1 billion in the prior quarter.
- Over the last five years, Cash & Current Investments for SYK reached as high as $4.6 billion in Q3 2024 and fell as low as $1.1 billion in Q2 2022.
- Historically, Cash & Current Investments has averaged $2.5 billion across 5 years, with a median of $2.3 billion in 2025.
- Across the five-year window, Cash & Current Investments sank 51.53% in 2022 and soared 137.6% in 2024, its largest moves.
- Year by year, Cash & Current Investments stood at $1.9 billion in 2022, then surged by 58.35% to $3.1 billion in 2023, then gained by 22.6% to $3.7 billion in 2024, then climbed by 9.54% to $4.1 billion in 2025, then retreated by 29.8% to $2.9 billion in 2026.
- Per Business Quant data, the three most recent Cash & Current Investments figures were $2.9 billion in Q1 2026, $4.1 billion in Q4 2025, and $3.3 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 1.12 Bn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 2.29 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 577.00 Mn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 3.12 Bn |
| 10 | Steris | 21.47 Bn | 21.03 Bn | 697.10 Mn | 439.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.88 Bn |
| Dec 31, 2025 | 4.10 Bn |
| Sep 30, 2025 | 3.34 Bn |
| Jun 30, 2025 | 2.38 Bn |
| Mar 31, 2025 | 2.32 Bn |
| Dec 31, 2024 | 3.74 Bn |
| Sep 30, 2024 | 4.60 Bn |
| Jun 30, 2024 | 1.96 Bn |
| Mar 31, 2024 | 2.41 Bn |
| Dec 31, 2023 | 3.05 Bn |
| Sep 30, 2023 | 1.94 Bn |
| Jun 30, 2023 | 1.48 Bn |
| Mar 31, 2023 | 1.76 Bn |
| Dec 31, 2022 | 1.93 Bn |
| Sep 30, 2022 | 1.50 Bn |
| Jun 30, 2022 | 1.13 Bn |
| Mar 31, 2022 | 1.53 Bn |
| Dec 31, 2021 | 3.02 Bn |
| Sep 30, 2021 | 2.64 Bn |
| Jun 30, 2021 | 2.33 Bn |